Currently, this project runs in the Federal Capital Territory, Abuja, Nasarawa, Rivers and Katsina states. As of March 2020, 469, 357 patients received care and support for HIV/AIDS, and 351,451 received ARV drugs and treatment under this project
Other projects include the United States Agency for International Development (USAID) Chemonics Strategic HIV/AIDS Response Program (SHARP) Task Order 1 and 3 projects being implemented in Sokoto, Niger, Zamfara, Kebbi, Kwara, Jigawa, Bauchi, Yobe and Adamawa States.
The 2019 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) pegged the country’s prevalence rate at 1.4%. However, this national percentage does not represent the prevalence in individual states. For instance, the state with the highest prevalence is Akwa Ibom State with 5.5% prevalence followed by Benue State with 5.3% prevalence and then Rivers State with 3.8% prevalence rate. It was estimated that about 79% of people living with HIV in Rivers State were not on treatment.
Therefore, as a leading implementing partner of the US PEPFAR funded HIV programs, through the US Centers for Disease Control and Prevention (CDC), Institute of Human Virology, Nigeria (IHVN) was mandated in April 2019 to spearhead a response to address this situation in Rivers State. IHVN had previously responded to a critical HIV prevalence in Benue State when the prevalence was higher than 5.3%.
There are 23 Local Government Areas in Rivers state, and about 117 health facilities are currently supported to provide HIV services.
The goal is to ensure that 199,577 persons infected with HIV know their status, place at least 170,166 PLHIVs on treatment by bridging the treatment gap from the present 21% to 81%, and attain viral suppression for at least 161,657 PLHIVs on treatment by September 2020.